OBJECTIVE: Heart failure (HF) is a known risk factor for cognitive impairment. Cardiac rehabilitation (CR) may attenuate poor neurocognitive outcomes in HF via improved physical fitness--a significant promoter of cognitive function. However, no study has examined the possible acute and lasting benefits of CR on cognitive function in persons with HF. METHODS AND RESULTS: Fifty-two patients with HF completed a 12-week Phase II CR program. All participants were administered neuropsychological testing and completed a brief physical fitness assessment at baseline, completion of CR (i.e. 12 weeks), and 12-month follow-up. Repeated measures analyses showed a significant time effect for both attention/executive function and memory (P < 0.05). Attention/executive function performance increased from baseline to 12 weeks and these gains remained up to 12 months; memory was unchanged from baseline to 12 weeks, but then improved between the 12-week and 12-month time points. Physical fitness improved from baseline to 12 weeks and these benefits were maintained 12 months later. Changes in physical fitness and cognitive function over time did not reach a statistically significant association, though poorer physical fitness was associated with decreased cognitive performance at the baseline and 12-month time points. CONCLUSIONS: CR is associated with both acute and lasting cognitive benefits in patients with HF. Prospective studies with extended follow-ups are needed to clarify the mechanisms that underpin cognitive improvements following CR (e.g., improved cerebral perfusion) and whether CR can ultimately reduce risk for cognitive decline and conditions like Alzheimer's disease in HF.
OBJECTIVE:Heart failure (HF) is a known risk factor for cognitive impairment. Cardiac rehabilitation (CR) may attenuate poor neurocognitive outcomes in HF via improved physical fitness--a significant promoter of cognitive function. However, no study has examined the possible acute and lasting benefits of CR on cognitive function in persons with HF. METHODS AND RESULTS: Fifty-two patients with HF completed a 12-week Phase II CR program. All participants were administered neuropsychological testing and completed a brief physical fitness assessment at baseline, completion of CR (i.e. 12 weeks), and 12-month follow-up. Repeated measures analyses showed a significant time effect for both attention/executive function and memory (P < 0.05). Attention/executive function performance increased from baseline to 12 weeks and these gains remained up to 12 months; memory was unchanged from baseline to 12 weeks, but then improved between the 12-week and 12-month time points. Physical fitness improved from baseline to 12 weeks and these benefits were maintained 12 months later. Changes in physical fitness and cognitive function over time did not reach a statistically significant association, though poorer physical fitness was associated with decreased cognitive performance at the baseline and 12-month time points. CONCLUSIONS: CR is associated with both acute and lasting cognitive benefits in patients with HF. Prospective studies with extended follow-ups are needed to clarify the mechanisms that underpin cognitive improvements following CR (e.g., improved cerebral perfusion) and whether CR can ultimately reduce risk for cognitive decline and conditions like Alzheimer's disease in HF.
Authors: Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy Journal: Circulation Date: 2009-03-26 Impact factor: 29.690
Authors: Michael L Alosco; Mary Beth Spitznagel; Lindsay Miller; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Donna Waechter; Joel Hughes; Jim Rosneck; John Gunstad Journal: Health Psychol Date: 2012-08-27 Impact factor: 4.267
Authors: J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark Journal: Neurology Date: 1989-09 Impact factor: 9.910
Authors: Rajesh Kumar; Mary A Woo; Bramley V X Birrer; Paul M Macey; Gregg C Fonarow; Michele A Hamilton; Ronald M Harper Journal: Neurobiol Dis Date: 2008-10-31 Impact factor: 5.996
Authors: Raymond L C Vogels; Joukje M Oosterman; Barbera van Harten; Alida A Gouw; Jutta M Schroeder-Tanka; Philip Scheltens; Wiesje M van der Flier; Henry C Weinstein Journal: Dement Geriatr Cogn Disord Date: 2007-10-15 Impact factor: 2.959
Authors: Sandra B Chapman; Sina Aslan; Jeffrey S Spence; Laura F Defina; Molly W Keebler; Nyaz Didehbani; Hanzhang Lu Journal: Front Aging Neurosci Date: 2013-11-12 Impact factor: 5.750
Authors: Michael L Alosco; Mary Beth Spitznagel; Ronald Cohen; Lawrence H Sweet; Scott M Hayes; Richard Josephson; Joel Hughes; John Gunstad Journal: J Card Fail Date: 2015-01-05 Impact factor: 5.712
Authors: Debra K Moser; Cynthia Arslanian-Engoren; Martha J Biddle; Misook Lee Chung; Rebecca L Dekker; Muna H Hammash; Gia Mudd-Martin; Abdullah S Alhurani; Terry A Lennie Journal: Curr Cardiol Rep Date: 2016-12 Impact factor: 2.931
Authors: Michael L Alosco; Adam M Brickman; Mary Beth Spitznagel; Atul Narkhede; Erica Y Griffith; Ronald Cohen; Lawrence H Sweet; Richard Josephson; Joel Hughes; John Gunstad Journal: J Cardiovasc Nurs Date: 2016 Jan-Feb Impact factor: 2.083
Authors: Michael L Alosco; Mary Beth Spitznagel; Ronald Cohen; Lawrence H Sweet; Richard Josephson; Joel Hughes; John Gunstad Journal: J Am Geriatr Soc Date: 2014-11 Impact factor: 5.562
Authors: Amber D Rochette; Mary Beth Spitznagel; Lawrence H Sweet; Ronald A Cohen; Richard Josephson; Joel Hughes; John Gunstad Journal: J Cardiovasc Nurs Date: 2017 May/Jun Impact factor: 2.083
Authors: Michael L Alosco; Mary Beth Spitznagel; Richard Josephson; Joel Hughes; John Gunstad Journal: Heart Lung Date: 2014-10-11 Impact factor: 2.210
Authors: Michael L Alosco; Adam M Brickman; Mary Beth Spitznagel; Lawrence H Sweet; Richard Josephson; Erica Y Griffith; Atul Narkhede; Joel Hughes; John Gunstad Journal: J Int Neuropsychol Soc Date: 2015-11 Impact factor: 2.892
Authors: Barbara Riegel; Debra K Moser; Harleah G Buck; Victoria Vaughan Dickson; Sandra B Dunbar; Christopher S Lee; Terry A Lennie; JoAnn Lindenfeld; Judith E Mitchell; Diane J Treat-Jacobson; David E Webber Journal: J Am Heart Assoc Date: 2017-08-31 Impact factor: 5.501